Cargando…

A Prospective Phase II Study of Simultaneous Modulated Accelerated Radiotherapy Concurrently With CDDP/S1 for Esophageal Squamous Cell Carcinoma in the Elderly

BACKGROUND: To explore the efficacy and toxicity of simultaneous modulated accelerated radiotherapy (SMART) concurrently with cisplatin (CDDP) and S1 (tegafur/gimeracil/oteracil) in elderly patients with esophageal squamous cell carcinoma (ESCC). METHODS: This single-arm, phase II study enrolled pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, SuPing, Liu, FangJie, Liu, Hui, Wu, YingJia, Zhang, XuHui, Ye, WenFeng, Luo, GuangYu, Li, QiWen, Chen, NaiBin, Hu, Nan, Wang, Bin, Zhang, Jun, Lin, MaoSheng, Feng, HuiXia, Qiu, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654786/ https://www.ncbi.nlm.nih.gov/pubmed/34900709 http://dx.doi.org/10.3389/fonc.2021.760631

Ejemplares similares

Moderately hypo-fractionated radiotherapy combined with S-1 in inoperable locally advanced esophageal squamous cell carcinoma: A prospective, single-arm phase II study (GASTO-1045)
por: Zhou, Rui, et al.
Publicado: (2023)

Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients
por: Liu, FangJie, et al.
Publicado: (2022)

Efficacy and cost‐effectiveness analysis of pretreatment percutaneous endoscopic gastrostomy in unresectable locally advanced esophageal cancer patients treated with concurrent chemoradiotherapy (GASTO 1059)
por: Ai, XinLei, et al.
Publicado: (2023)

An esophagus-sparing technique to limit radiation esophagitis in locally advanced non-small cell lung cancer treated by simultaneous integrated boost intensity-modulated radiotherapy and concurrent chemotherapy
por: Ma, Li, et al.
Publicado: (2018)

Evaluation of the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy in atypical histologic subtypes of primary and metastatic mediastinal malignancies
por: Meng, FanJun, et al.
Publicado: (2022)

GADD45α alleviates the CDDP resistance of SK-OV3/cddp cells via redox-mediated DNA damage
por: Zhang, Qi-Zhu, et al.
Publicado: (2021)

Effect of TTLL6 expression on CDDP sensitivity of EC109/CDDP cells in hypoxia/acidosis microenvironment
por: Qiu, Yang, et al.
Publicado: (2020)

The effects of co-administration of selenium and cis-platin (CDDP) on CDDP-induced toxicity and antitumour activity.
por: Ohkawa, K., et al.
Publicado: (1988)

Association of ABCC2 and CDDP-Resistance in Two Sublines Resistant to CDDP Derived from a Human Nasopharyngeal Carcinoma Cell Line
por: Xie, Si Ming, et al.
Publicado: (2010)

A pilot trial of consolidation bevacizumab after hypo‐fractionated concurrent chemoradiotherapy in patients with unresectable locally advanced non‐squamous non‐small‐cell lung cancer
por: Huo, LanQing, et al.
Publicado: (2023)

Why Concurrent CDDP and Radiotherapy Has Synergistic Antitumor Effects: A Review of In Vitro Experimental and Clinical-Based Studies
por: Nagasawa, Shinsuke, et al.
Publicado: (2021)

Feasibility and efficiency of concurrent chemoradiotherapy with capecitabine and cisplatin versus radiotherapy alone for elderly patients with locally advanced esophageal squamous cell carcinoma: Experience of two centers
por: Chen, Fangjie, et al.
Publicado: (2017)

Metformin inhibits the proliferation of A549/CDDP cells by activating p38 mitogen-activated protein kinase
por: WANG, YAJUN, et al.
Publicado: (2014)

pH-Responsive Fluorescence Enhanced Nanogel for Targeted Delivery of AUR and CDDP Against Breast Cancer
por: Cao, Zhiwen, et al.
Publicado: (2020)

Feasibility and efficiency of concurrent chemoradiotherapy with a single agent or double agents vs radiotherapy alone for elderly patients with esophageal squamous cell carcinoma: Experience of two centers
por: Huang, Chunyue, et al.
Publicado: (2019)

The effects of aspirin plus cisplatin on SGC7901/CDDP cells in vitro
por: DONG, HANZHANG, et al.
Publicado: (2014)

The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (HSCLC) cell line.
por: Hospers, G. A., et al.
Publicado: (1990)

Targeting claudin-4 enhances CDDP-chemosensitivity in gastric cancer
por: Nishiguchi, Yukiko, et al.
Publicado: (2019)

Pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal cancer
por: Pao, Tzu-Hui, et al.
Publicado: (2020)

TRIM37 contributes to malignant outcomes and CDDP resistance in gastric cancer
por: Nishibeppu, Keiji, et al.
Publicado: (2021)

A New Candidate Supporting Drug, Rikkunshito, for the QOL in Advanced Esophageal Cancer Patients with Chemotherapy Using Docetaxel/5-FU/CDDP
por: Seike, Junichi, et al.
Publicado: (2011)

Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma
por: Pao, Tzu-Hui, et al.
Publicado: (2021)

Inhibitory effect of STAT3 gene combined with CDDP on growth of human Wilms tumour SK-NEP-1 cells
por: Wang, Junrong, et al.
Publicado: (2016)

Cisplatin sensitivity and thermochemosensitisation in thermotolerant cDDP-sensitive and -resistant cell lines.
por: Hettinga, J. V., et al.
Publicado: (1995)

Tumor-associated fibroblast-conditioned medium induces CDDP resistance in HNSCC cells
por: Steinbichler, Teresa Bernadette, et al.
Publicado: (2015)

A Meta-Analysis of Concurrent Chemoradiotherapy for Advanced Esophageal Cancer
por: Zhu, Li-Li, et al.
Publicado: (2015)

Concurrent cisplatin and 5-fluorouracil versus concurrent cisplatin and docetaxel with radiotherapy for esophageal squamous cell carcinoma: a propensity score-matched analysis
por: Zhang, Peng, et al.
Publicado: (2016)

Concurrent chemoradiotherapy combined with enteral nutrition support: a radical treatment strategy for esophageal squamous cell carcinoma patients with malignant fistulae
por: Ma, Li, et al.
Publicado: (2017)

Analysis of Biochemical and Genetic Variability of Pleurotus ostreatus Based on the β-Glucans and CDDP Markers
por: Golian, Marcel, et al.
Publicado: (2022)

Enrichment of Wee1/CDC2 and NF-κB Signaling Pathway Constituents Mutually Contributes to CDDP Resistance in Human Osteosarcoma
por: Hu, Zhengbo, et al.
Publicado: (2022)

Exosomes Mediated Transfer of Circ_0000337 Contributes to Cisplatin (CDDP) Resistance of Esophageal Cancer by Regulating JAK2 via miR-377-3p
por: Zang, Rukun, et al.
Publicado: (2021)

Cardiac Dose Predicts the Response to Concurrent Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
por: Ho, Yu-Chieh, et al.
Publicado: (2023)

Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin
por: Jia, Yunlong, et al.
Publicado: (2021)

Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma Incorporating Hematological Biomarkers
por: Wu, Yingjia, et al.
Publicado: (2021)

Cytotoxicity of thymoquinone alone or in combination with cisplatin (CDDP) against oral squamous cell carcinoma in vitro
por: Alaufi, Omar M., et al.
Publicado: (2017)

MicroRNA-765 Enhances the Anti-Angiogenic Effect of CDDP via APE1 in Osteosarcoma
por: Liang, Wei, et al.
Publicado: (2017)

A case of primary ovarian signet-ring cell carcinoma treated with S-1/CDDP therapy
por: Shoji, Tadahiro, et al.
Publicado: (2020)

Efficacy and safety of concurrent anti-tuberculosis treatment and chemotherapy in lung cancer patients with co-existent tuberculosis
por: Ye, Mei-Feng, et al.
Publicado: (2020)

Role of argon plasma coagulation in treatment of esophageal varices
por: Song, Ying, et al.
Publicado: (2021)

Expression of SLP-2 Was Associated with Invasion of Esophageal Squamous Cell Carcinoma
por: Cao, Wenfeng, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_up3okb9lkg8ntmvde842lbab4b